- Home
- Labeler Index
- Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc
- 0955-3900
- NDC Crossover: 0955-3900 Insulin Glargine U-300
NDC Crossover 0955-3900 Insulin Glargine U-300
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 0955-3900 Insulin Glargine U-300 a human prescription drug with other products crossover matching the same product name (Insulin Glargine U-300) or generic name (Insulin Glargine), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0024-5869 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0024-5871 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 0955-2900 | Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | Human Prescription Drug |
| 50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
| 50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |